Quick Answer
CHAMPIONS ONCOLOGY, INC. reported Stockholders Equity of $3.77 million for the year ending 2025.
- CHAMPIONS ONCOLOGY, INC. showed an increase of +298.2% in Stockholders Equity from 2024 to 2025.
- This data is from CHAMPIONS ONCOLOGY, INC.'s annual report (Form 10-K), filed with the SEC on July 23, 2025.
- XBRL data for this metric is available from 2010 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: -$5.28 million | Q3 2012: -$5.84 million | Q4 2012: -$7.18 million | Q1 2013: -$7.60 million | Q3 2013: -$10.90 million | Q4 2013: -$12.74 million | Q1 2014: $4.49 million | Q3 2014: $439.0 thousand | Q4 2014: -$1.86 million | Q1 2015: -$4.14 million | Q3 2015: $5.90 million | Q4 2015: $4.10 million | Q1 2016: $2.26 million | Q4 2016: $3.21 million | Q1 2017: $2.04 million | Q3 2017: $290.0 thousand | Q4 2017: $373.0 thousand | Q1 2018: $472.0 thousand | Q3 2018: $603.0 thousand | Q4 2018: $1.99 million | Q1 2019: $2.32 million | Q3 2019: $1.73 million | Q4 2019: $2.11 million | Q1 2020: $5.51 million | Q3 2020: $5.51 million | Q4 2020: $6.89 million | Q1 2021: $8.09 million | Q3 2021: $7.54 million | Q4 2021: $8.07 million | Q1 2022: $9.24 million | Q3 2022: $8.98 million | Q4 2022: $9.17 million | Q1 2023: $7.06 million | Q3 2023: $1.90 million | Q4 2023: $93.0 thousand | Q1 2024: -$2.06 million | Q3 2024: -$332.0 thousand | Q4 2024: $681.0 thousand | Q1 2025: $5.47 million | Q2 2025: $3.77 million | Q3 2025: $3.51 million | Q4 2025: $4.17 million | Q1 2026: $4.28 million.
- Over the full 17 years of available data (2010 to 2025), CHAMPIONS ONCOLOGY, INC.'s Stockholders Equity has grown by 139.2%.
- Historical annual values: Fiscal year 2025: $3.77 million | Fiscal year 2024: -$1.90 million | Fiscal year 2023: $4.64 million | Fiscal year 2022: $9.10 million | Fiscal year 2021: $7.43 million | Fiscal year 2021: $8.09 million | Fiscal year 2020: $5.10 million | Fiscal year 2019: $2.14 million | Fiscal year 2018: $3.0 thousand | Fiscal year 2017: $400.0 thousand | Fiscal year 2016: $238.0 thousand | Fiscal year 2015: $8.06 million | Fiscal year 2014: $3.20 million | Fiscal year 2013: -$9.21 million | Fiscal year 2012: -$5.28 million | Fiscal year 2011: $19.0 thousand | Fiscal year 2010: $1.58 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: